Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Marius Pharmaceuticals LLC
Marius Pharmaceuticals Partners with UK-Based Numan to Combat Testosterone Deficiency with KYZATREX® (Testosterone Undecanoate) CIII Capsules
September 18, 2024
From
Marius Pharmaceuticals LLC
Via
GlobeNewswire
Marius Pharmaceuticals Submits KYZATREX® (Testosterone Undecanoate) CIII Capsules for Approval to Health Canada
July 30, 2024
From
Marius Pharmaceuticals LLC
Via
GlobeNewswire
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023
From
Marius Pharmaceuticals LLC
Via
GlobeNewswire
Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)
August 10, 2023
From
Marius Pharmaceuticals LLC
Via
GlobeNewswire
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
July 24, 2023
From
Marius Pharmaceuticals LLC
Via
GlobeNewswire
Marius Pharmaceuticals Supports AXYS 2023 Virtual Family Conference, Spotlighting KYZATREX™ for XY Chromosome Variations, such as Klinefelter’s Syndrome
June 20, 2023
From
Marius Pharmaceuticals LLC
Via
GlobeNewswire
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
June 09, 2023
From
Marius Pharmaceuticals LLC
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.